1 Telmisartan as a metabolic sartan: The first meta-analysis of randomized controlled trials in metabolic syndrome Journal of the American Society of Hypertension, April 24, 2013
2 Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report Cardiovascular Diabetology, May 15, 2013
3 Obesity and prostate cancer: weighing the evidence European Urology, May 3, 2013 Review Article
4 A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes Diabetic Medicine, May 15, 2013
5 Racial/ethnic Differences in Clinical and Biochemical Type 2 Diabetes Mellitus Risk Factors in Children Obesity, April 18, 2013 Review Article
6 Omega-3 Polyunsaturated Fatty Acids Increase Plasma Adiponectin to Leptin Ratio in Stable Coronary Artery Disease Cardiovascular Drugs and Therapy, April 22, 2013
7 Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes Cardiovascular Diabetology, April 30, 2013 Review Article
8 Non-Alcoholic Fatty Liver Disease (Nafld) Independently Predicts Pre-Diabetes During A Seven-Year Prospective Follow-Up Liver International, April 30, 2013
9 Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study Cancer Epidemiology, Biomarkers & Prevention, May 10, 2013
10 Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Womens Health Initiative Breast Cancer Research and Treatment, May 3, 2013 Review Article
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor